Author:
María Patricia Hernández-Mitre,Susan Morpeth,Balasubramanian Venkatesh,Thomas Hills,Joshua Davis,Robert Mahar,Grace McPhee,Mark Jones,James Totterdell,Steven Tong,Jason Roberts
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference46 articles.
1. World Health Organization. WHO COVID-19 Dashboard. 2020. https://www.who.int/data/stories/the-true-death-toll-of-covid-19-estimating-global-excess-mortality (accessed Aug 30, 2023).
2. Pharmacokinetics/Pharmacodynamics of Antiviral Agents Used to Treat SARS-CoV-2 and Their Potential Interaction with Drugs and Other Supportive Measures: A Comprehensive Review by the PK/PD of Anti-Infectives Study Group of the European Society of Antimicr;Zeitlinger;Clin Pharmacokinet,2020
3. Nafamostat Mesilate;Okajima;Cardiovasc Drug Rev,1995
4. Nichi-Iko Pharmaceutical Co. Ltd. Pharmaceutical interview form for FUTHAN 10 INJ., FUTHAN 50 INJ. 6th Edition (Japanese). 2019. https://www.nichiiko.co.jp/medicine/file/31050/interview (accessed Aug 30, 2023).
5. Nichi-Iko Pharmaceutical Co. Ltd. Pharmaceutical Interview Form. Nafamostat Mesylate. 8th Edition (Japanese). 2022. https://www.nichiiko.co.jp/medicine/file/31050/interview (accessed Aug 30, 2023).